Fulvestrant Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-08-14 · last update 2026-08-14
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Fulvestrant, Injection, 250 mg per 5mL (NDC 63323-715-05) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 08/14/2026 Updated 08/14/2026 Discontinued 08/14/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)